Swine Fever Vaccine Market, by Type (African Swine Fever and Classical Swine Fever), by Vaccine Type (Live-Attenuated, Chimeric (Live-attenuated or inactivated), Subunit or vector system based, and Replicon vaccine), by Distribution Channel (Public and Pr
Swine Fever Vaccine Market, by Type (African Swine Fever and Classical Swine Fever), by Vaccine Type (Live-Attenuated, Chimeric (Live-attenuated or inactivated), Subunit or vector system based, and Replicon vaccine), by Distribution Channel (Public and Private), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2024 - 2031
There are two types of swine fever – Classical Swine Fever (CSF) and African Swine Fever (ASF). Classical swine fever (CSF) is an extremely contagious viral disease in pigs. The severity of the disease varies with the strain of the virus, the immune status of the herd, and the age of the pig. African swine fever, on the other hand, is a highly contagious and deadly viral disease affecting both domestic and feral swine of all ages. Acute forms of both ASF and CSF can cause high death rates, with mortality approaching 100% in the most severe form of ASF. Both diseases may also occur in milder forms with lower mortality rates. Swine fever could be considered a possibility in case of a sudden increase in deaths in a group of pigs. Clinical signs of acute forms of both ASF and CSF include depression, fever, loss of appetite, and red, purple, or blue blotching of the ears, nose, and limbs. Vomiting and diarrhea (bloody diarrhea for ASF) may occur as the disease progresses, along with breathing difficulties and coughing. The diseases spread through direct contact with infected pigs or contact with contaminated pens, trucks, or clothing. In both diseases, pigs can remain carriers of the disease for long period and therefore moving pigs during an outbreak must be restricted.
Market Dynamics
Increasing efforts by the government bodies to create awareness and prevent the spread of swine fever by organizing awareness campaigns are expected to drive the market growth over the forecast period. For instance, in June 2022, the United States Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) announced new efforts to help prevent the introduction and spread of African swine fever in the U.S. Through an outreach and awareness campaign called “Protect Our Pigs,” APHIS will support commercial pork producers, veterinarians, and pig owners with information and resources to help safeguard America’s swine population and the pork industry.
Key features of the study:
This report provides an in-depth analysis of the global swine fever vaccine market, market size (US$ Million), and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global swine fever vaccine market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Merck & Co., Inc. (Merck Animal Health), Ceva, Zoetis Services LLC, Boehringer Ingelheim International GmbH, Indian Immunologicals Ltd., Bioveta, a.s., Komipharm, and EC21 Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global swine fever vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global swine fever vaccine market
Detailed Segmentation:
Global Swine Fever Vaccine Market, By Type:
African Swine Fever
Classical Swine Fever
Global Swine Fever Vaccine Market, By Vaccine Type:
Live-Attenuated
Chimeric (Live-attenuated or inactivated)
Subunit or vector system based
Replicon vaccine
Global Swine Fever Vaccine Market, By Distribution Channel:
Public
Private
Global Swine Fever Vaccine Market, By Region:
North America
Latin America
Europe
Asia Pacific
Middle East
Africa
Company Profiles
Merck & Co., Inc. (Merck Animal Health)
Ceva
Zoetis Services LLC
Boehringer Ingelheim International GmbH
Indian Immunologicals Ltd.
Bioveta, a.s.
Komipharm
EC21 Inc.
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Type
Market Snapshot, By Vaccine Type
Market Snapshot, By Distribution Channel
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Market Trends
Epidemiology
Regulatory Scenario
PEST Analysis
New Product Approval/Launch
4. Global Swine Fever Vaccine Market - Impact of Coronavirus (COVID-19) Pandemic
Economic Impact
COVID-19 Epidemiology
Demand and Supply Analysis
5. Global Swine Fever Vaccine Market, By Type, 2019 – 2031, (US$ Million)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 – 2031
Segment Trends
African Swine Fever
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Million)
Classical Swine Fever
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Million)
6. Global Swine Fever Vaccine Market, By Vaccine Type, 2019 – 2031, (US$ Million)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 – 2031
Segment Trends
Live-Attenuated
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Million)
Chimeric (Live-attenuated or inactivated)
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Million)
Subunit or vector system based
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Million)
Replicon vaccine
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Million)
7. Global Swine Fever Vaccine Market, By Distribution Channel, 2019 – 2031, (US$ Million)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 – 2031
Segment Trends
Public
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Million)
Private
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Million)
8. Global Swine Fever Vaccine Market, By Region, 2019 – 2031, (US$ Million)
Introduction
Market Share Analysis, By Region, 2024 and 2031 (%)
Y-o-Y Growth Analysis, By Region, 2020–2031
Regional Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (US$ Million)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (US$ Million)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (US$ Million)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 – 2031, (US$ Million)